Prime Medicine, Inc. insider trading

PRMENASDAQ

$3.21+0.23 (+7.72% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-47.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25

Unlock quarterly net flow

Key players

DRDavid R. Liu10% Owner11.1596%of company
RNRobert NelsenDirector10.2014%of company
KMKeith Michael GottesdienerSee Remarks2.4044%of company
ARAllan ReineChief Executive Officer0.0689%of company
ALAnn L. LeeChief Technical Officer0.0551%of company
RBRichard BrudnickChief Business Officer0.011%of company
AIAlphabet Inc.10% OwnerNot reportedof company
AVARCH Venture Fund XII, L.P.10% OwnerNot reportedof company
SGSteven Gillis10% OwnerNot reportedof company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
No qualifying insider activity was found for the selected filters.

End of history · 0 transactions